230 related articles for article (PubMed ID: 29200119)
21. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
22. Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma.
Koral K; Gargan L; Bowers DC; Gimi B; Timmons CF; Weprin B; Rollins NK
AJR Am J Roentgenol; 2008 Mar; 190(3):809-14. PubMed ID: 18287456
[TBL] [Abstract][Full Text] [Related]
23. The genetics of pediatric brain tumors.
Dubuc AM; Northcott PA; Mack S; Witt H; Pfister S; Taylor MD
Curr Neurol Neurosci Rep; 2010 May; 10(3):215-23. PubMed ID: 20425037
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment.
Funakoshi Y; Hata N; Kuga D; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Mizoguchi M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673070
[TBL] [Abstract][Full Text] [Related]
25. Pediatric Basal Ganglia Region Tumors: Clinical and Radiologic Features Correlated with Histopathologic Findings.
Fu W; Ju Y; Zhang S; You C
World Neurosurg; 2017 Jul; 103():504-516. PubMed ID: 28408259
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
27. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
Pollack IF
J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
[TBL] [Abstract][Full Text] [Related]
28. Posterior fossa tumors in children: An update and new concepts.
Mengide JP; Berros MF; Turza ME; Liñares JM
Surg Neurol Int; 2023; 14():114. PubMed ID: 37151431
[TBL] [Abstract][Full Text] [Related]
29. The new WHO 2016 classification of brain tumors-what neurosurgeons need to know.
Banan R; Hartmann C
Acta Neurochir (Wien); 2017 Mar; 159(3):403-418. PubMed ID: 28093610
[TBL] [Abstract][Full Text] [Related]
30. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract][Full Text] [Related]
31. 2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know.
Johnson DR; Guerin JB; Giannini C; Morris JM; Eckel LJ; Kaufmann TJ
Radiographics; 2017; 37(7):2164-2180. PubMed ID: 29028423
[TBL] [Abstract][Full Text] [Related]
32. Molecular changes in brain tumors: prognostic and therapeutic impact.
Sanson M; Laigle-Donadey F; Benouaich-Amiel A
Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
[TBL] [Abstract][Full Text] [Related]
33. Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers.
Huttner A
Hematol Oncol Clin North Am; 2012 Aug; 26(4):715-32. PubMed ID: 22794280
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology of pediatric brain tumors and impact on novel therapies.
Hoffman LM; Salloum R; Fouladi M
Curr Neurol Neurosci Rep; 2015 Apr; 15(4):10. PubMed ID: 25690927
[TBL] [Abstract][Full Text] [Related]
35. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid.
Ho CY; VandenBussche CJ; Huppman AR; Chaudhry R; Ali SZ
Cancer Cytopathol; 2015 Feb; 123(2):123-35. PubMed ID: 25487367
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
Mühlisch J; Schwering A; Grotzer M; Vince GH; Roggendorf W; Hagemann C; Sörensen N; Rickert CH; Osada N; Jürgens H; Frühwald MC
Oncogene; 2006 Feb; 25(7):1111-7. PubMed ID: 16186793
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetics and molecular genetics of childhood brain tumors.
Biegel JA
Neuro Oncol; 1999 Apr; 1(2):139-51. PubMed ID: 11550309
[TBL] [Abstract][Full Text] [Related]
38. Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case Series.
Bächli H; Ecker J; van Tilburg C; Sturm D; Selt F; Sahm F; Koelsche C; Grund K; Sutter C; Pietsch T; Witt H; Herold-Mende C; von Deimling A; Jones D; Pfister S; Witt O; Milde T
Klin Padiatr; 2018 Oct; 230(6):305-313. PubMed ID: 29996150
[TBL] [Abstract][Full Text] [Related]
39. Oncogene amplification in pediatric brain tumors.
Wasson JC; Saylors RL; Zeltzer P; Friedman HS; Bigner SH; Burger PC; Bigner DD; Look AT; Douglass EC; Brodeur GM
Cancer Res; 1990 May; 50(10):2987-90. PubMed ID: 2334901
[TBL] [Abstract][Full Text] [Related]
40. Pediatric gliomas.
Pfister S; Witt O
Recent Results Cancer Res; 2009; 171():67-81. PubMed ID: 19322538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
